Cancer – Page 42 – Communicable Diseases Research

Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic

임상 실습의 최근 발전: COVID-19 대유행 중 염증성 장 질환 관리

Review

Published on 2022-07-012022-09-11
Journal: Gut [Category] COVID19(2023년), SARS, 치료기술,

[키워드] acquisition adverse outcome adverse outcomes antibody booster dose bowel Breakthrough infection breakthrough infections Cancer cancers Corticosteroid Corticosteroids COVID-19 COVID-19 in patient COVID-19 pandemic Crohn's disease de novo decrease develop diagnoses disease course dose Evidence Future General population Guidance hospitalisation hospitalisations Humoral response humoral responses IBD immune immune response immunosuppressive therapies immunosuppressive therapy increased risk Inflammatory Inflammatory bowel disease management medication medications Necrosis outcome outcomes pandemic Patient patients potential risk primary dose raised receive recent remained Research risk risk of COVID-19 SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 vaccines TNF treated Treatment ulcerative ulcerative colitis Vaccine vaccine response Vaccines
[DOI] 10.1136/gutjnl-2021-326784 PMC 바로가기 [Article Type] Review

Immunogenicity and early clinical outcome after two or three doses of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: results from the prospective observational Vax-On-Third study

적극적으로 치료받는 암 환자에서 SARS-CoV-2 mRNA-BNT162b2 백신 2~3회 투여 후 면역원성과 초기 임상 결과: 전향적 관찰 Vax-On-Third 연구 결과

Observational Study

Published on 2022-07-012022-09-12
Journal: Annals of oncology : official journal of the Europ [Category] COVID19(2023년), MERS, SARS, 임상, 진단,

[키워드] Cancer Clinical outcome dose immunogenicity SARS-CoV-2 treated Vaccine
[DOI] 10.1016/j.annonc.2022.04.002 PMC 바로가기 [Article Type] Observational Study

COVID-19 patient with B Cell Lymphoma co-morbidity managed with co-administration of Ayurvedic formulation

Case report

Published on 2022-07-012022-10-05
Journal: Journal of Ayurveda and Integrative Medicine [Category] 진단, 치료제,

Survey on the effectiveness of telephone-based communication with relatives of hospitalized cancer patients in COVID-19 era in Italy

Article

Published on 2022-07-012023-07-08
Journal: Supportive Care in Cancer [Category] COVID19(2023년),

[키워드] Cancer Communication. COVID-19
[DOI] 10.1007/s00520-022-07042-1 PMC 바로가기

mRNA vaccines: Past, present, future

Review article

Published on 2022-07-012022-10-05
Journal: Asian Journal of Pharmaceutical Sciences [Category] 비임상,

[키워드] addition adjuvant Cancer candidate carrier Clinical use conventional vaccines COVID-19 Diseases ENhance in vitro Lipid nanoparticles mRNA mRNA stability mRNA vaccine Nanoparticles outcomes Pandemics platform provide provided RNA safety profile shown tissue transcribed Treatment vaccine platform viral disease virus widespread
[DOI] 10.1016/j.ajps.2022.05.003 [Article Type] Review article

Milano Policlinico ONCOVID modified Score for risk evaluation in oncology during the COVID-19 pandemic: a prospective monocentric study

Article

Published on 2022-07-012023-07-08
Journal: Supportive Care in Cancer [Category] COVID19(2023년),

[키워드] Cancer COVID-19 Milano Policlinico ONCOVID Score.
[DOI] 10.1007/s00520-022-07040-3 PMC 바로가기

Effects of the COVID-19 pandemic on care of melanoma patients in Berlin, Germany: the Mela-COVID survey

Article

Published on 2022-07-012023-07-10
Journal: European journal of dermatology : EJD [Category] COVID19(2023년),

[키워드] Anxiety Cancer COVID-19 Melanoma pandemic SARS-CoV-2
[DOI] 10.1684/ejd.2021.4098 PMC 바로가기

Discovery Proteomics Analysis Determines That Driver Oncogenes Suppress Antiviral Defense Pathways Through Reduction in Interferon-β Autocrine Stimulation

Discovery Proteomics 분석을 통해 드라이버 종양유전자가 인터페론-β 자가분비 자극 감소를 통해 항바이러스 방어 경로를 억제한다는 사실이 확인되었습니다.

Article

Published on 2022-07-012022-09-11
Journal: Molecular & Cellular Proteomics : MCP [Category] COVID19(2023년), SARS, 유전자 메커니즘, 치료법,

[키워드] activated AKT Antiviral approach autocrine BRAF c-MYC Cancer cancer cell line cancer cell lines cancers Cell cell line cellular DDX58 develop double-stranded double-stranded RNA downregulation driven by driving dsRNA EGFR expression functional hallmark HER2 immune evasion Infection interferon KRAS lower expression MEK molecular MYC OAS oncogene oncogenes. oncogenic osteosarcoma Pancreatic cancer phenotypic profiles Protein Proteins proteome provide reduced regulated response RIG-I RNA virus SARS-CoV-2 shown Stimulation susceptibility susceptibility to infection therapeutic treated type 1 interferon
[DOI] 10.1016/j.mcpro.2022.100247 PMC 바로가기 [Article Type] Article

Tumor marker response to SARS-CoV-2 infection among patients with cancer

암 환자의 SARS-CoV-2 감염에 대한 종양 표지자 반응

Article

Published on 2022-07-012022-09-11
Journal: Cancer Medicine [Category] COVID19(2023년), MERS, SARS, 바이오마커,

[키워드] Antigen available data Cancer cancer diagnosis Cancer management cancer patient Cancer patients cancer progression carbohydrate Carcinoembryonic antigen Case series case sery CEA clinical Clinical data Clinical management clinical observations condition conducted coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 infection demographics Diagnosis Electronic health record Elevation Evidence evidence of Health health record implication induce Infection Inflammatory response Inflammatory responses knowledge Laboratory Laboratory test malignancy marker occurred Patient patients Patients with cancer patients with COVID-19 PCR test positive SARS-CoV-2 PCR positive SARS-CoV-2 PCR test Post-infection Research respiratory Respiratory Coronavirus response resulting SARS-CoV-2 SARS-COV-2 infection severe acute respiratory coronavirus severity of COVID-19 solid tumor Treatment Tumor tumor marker tumor markers Viral viral infection
[DOI] 10.1002/cam4.4646 PMC 바로가기 [Article Type] Article

Drug repurposing for the treatment of COVID-19

COVID-19 치료를 위한 약물 용도 변경

Review

Published on 2022-07-012022-09-11
Journal: Journal of pharmacological sciences [Category] COVID19(2023년), SARS, 변종, 신약개발, 치료법, 치료제,

[키워드] activity acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age aggravation approved Cancer cardiomyocyte cardiovascular disease coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 diabetes drug Drug repurposing Eco-pharma global effort global efforts heart failure hypertension increase mammalian cells mechanism Mortality NADPH NADPH oxidase outcome Patient prevalent protein-protein interaction Protein–protein interaction receptor receptor potential reported Research risk Safe SARS-CoV-2 SARS-COV-2 infection severe acute respiratory syndrome Coronavirus severe COVID-19 severity of COVID-19 shown therapeutic therapeutic agent therapeutic agents Transient Transient receptor potential channel. Treatment vaccine-resistant variant Vaccine-resistant variants virus Wuhan Wuhan, China
[DOI] 10.1016/j.jphs.2022.04.007 PMC 바로가기 [Article Type] Review